SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-229388"
 

Search: onr:"swepub:oai:DiVA.org:uu-229388" > Immunotherapy targe...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003053naa a2200421 4500
001oai:DiVA.org:uu-229388
003SwePub
008140806s2014 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2293882 URI
024a https://doi.org/10.2217/IMT.13.1622 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
100a Lindström, Veronicau Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)veher764
2451 0a Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders
264 1c 2014
338 a print2 rdacarrier
520 a Immunotherapy targeting a-synuclein has evolved as a potential therapeutic strategy for neurodegenerative diseases, such as Parkinson's disease, and initial studies on cellular and animal models have shown promising results. alpha-synuclein vaccination of transgenic mice reduced the number of brain inclusions, whereas passive immunization studies demonstrated that antibodies against the C-terminus of alpha-synuclein can pass the blood-brain barrier and affect the pathology. In addition, preliminary evidence suggests that transgenic mice treated with an antibody directed against alpha-synuclein oligomers/protofibrils resulted in reduced levels of such species in the CNS. The underlying mechanisms of immunotherapy are not yet fully understood, but may include antibody-mediated clearance of pre-existing aggregates, prevention of protein propagation between cells and microglia-dependent protein clearance. Thus, immunotherapy targeting alpha-synuclein holds promise, but needs to be further developed as a future disease-modifying treatment in Parkinson's disease and other alpha-synucleinopathies.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Immunologi inom det medicinska området0 (SwePub)301102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Immunology in the medical area0 (SwePub)301102 hsv//eng
653 a alpha-synuclein
653 a antibody
653 a immunization
653 a immunotherapy
653 a Parkinson's disease
700a Ihse, Elisabetu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)elihs048
700a Fagerqvist, Thereseu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)thewa743
700a Bergström, Joakimu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)joakberg
700a Nordstrom, Eva4 aut
700a Moller, Christer4 aut
700a Lannfelt, Larsu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)lalan021
700a Ingelsson, Martinu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)maing121
710a Uppsala universitetb Geriatrik4 org
773t Immunotherapyg 6:2, s. 141-153q 6:2<141-153x 1750-743Xx 1750-7448
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-229388
8564 8u https://doi.org/10.2217/IMT.13.162

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view